Moreover, since mutations in ATM encoding protein are involved in DNA repair mechanisms, ATM-aberrations may also sensitize BC cells to platinum drugs or PARP inhibitors in triple-negative BC, similarly to the effect of BRCA1 mutations. This evidence concerns the gene ATM and breast cancer.